Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DORNASE ALFA for Infective pulmonary exacerbation of cystic fibrosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 78 adverse event reports in the FDA FAERS database where DORNASE ALFA was used for Infective pulmonary exacerbation of cystic fibrosis.

Most Reported Side Effects for DORNASE ALFA

Side Effect Reports % Deaths Hosp.
No adverse event 889 16.4% 1 3
Cystic fibrosis 565 10.4% 7 471
Off label use 522 9.6% 23 94
Hospitalisation 512 9.4% 3 432
Pneumonia 377 6.9% 37 321
Condition aggravated 304 5.6% 27 250
Dyspnoea 246 4.5% 24 197
Infective pulmonary exacerbation of cystic fibrosis 245 4.5% 2 204
Product storage error 242 4.5% 0 1
Death 225 4.1% 222 10
Cough 195 3.6% 1 82
Intercepted medication error 125 2.3% 0 1
Intentional product use issue 121 2.2% 5 20
Lung disorder 117 2.2% 2 95
Intercepted product storage error 115 2.1% 0 0

Other Indications for DORNASE ALFA

Cystic fibrosis (2,769) Product used for unknown indication (1,615) Bronchiectasis (137) Cystic fibrosis lung (79) Lung disorder (59) Chronic respiratory failure (36) Chronic obstructive pulmonary disease (34) Pneumonia (33) Interstitial lung disease (31) Asthma (30)

Other Drugs Used for Infective pulmonary exacerbation of cystic fibrosis

AZTREONAM LYSINE (185) TOBRAMYCIN (144) CIPROFLOXACIN (62) MEROPENEM (44) VANCOMYCIN (42) PIPERACILLIN\TAZOBACTAM (26) OSELTAMIVIR (24) PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE (18) ELEXACAFTOR\IVACAFTOR\TEZACAFTOR (13) LINEZOLID (12)

Related Pages

DORNASE ALFA Full Profile All Infective pulmonary exacerbation of cystic fibrosis Drugs DORNASE ALFA Demographics DORNASE ALFA Timeline